Ischemic heart disease and stroke in relation to blood DNA methylation

Epidemiology

Volumn 21, Issue 6, 2010, Pages 819-828

  Baccarelli, Andrea ^a,b   Wright, Robert ^b,c   Bollati, Valentina ^a   Litonjua, Augusto ^c   Zanobetti, Antonella ^b   Tarantini, Letizia ^a   Sparrow, David ^d,e   Vokonas, Pantel ^d,e   Schwartz, Joel ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; DIASTOLIC BLOOD PRESSURE; DNA METHYLATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; RISK FACTOR; STROKE;

AGED; BOSTON; CROSS-SECTIONAL STUDIES; DNA METHYLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MYOCARDIAL ISCHEMIA; POLYMERASE CHAIN REACTION; STROKE;

EID: 77958489643     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181f20457     Document Type: Article

References (37)

1. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature. 2007;447:433-440.
2. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res. 2004;32:e38.
3. Weisenberger DJ, Campan M, Long TI, et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res. 2005;33: 6823-6836.
4. Ostertag EM, Kazazian HH Jr. Biology of mammalian L1 retrotrans-posons. Annu Rev Genet. 2001;35:501-538.
5. Schulz WA. L1 retrotransposons in human cancers. J Biomed Biotech-nol. 2006;2006:83672.
6. Han JS, Szak ST, Boeke JD. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature. 2004;429:268-274.
7. Turunen MP, Aavik E, Yla-Herttuala S. Epigenetics and atherosclerosis. Biochim Biophys Acta. 2009;1790:886-891.
8. Hiltunen MO, Yla-Herttuala S. DNA methylation, smooth muscle cells, and atherogenesis. Arterioscler Thromb Vasc Biol. 2003;23:1750-1753.
9. Yideng J, Jianzhong Z, Ying H, et al. Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs. DNA Cell Biol. 2007; 26:603-611.
10. Hiltunen MO, Turunen MP, Hakkinen TP, et al. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med. 2002;7:5-11.
11. Castro R, Rivera I, Struys EA, et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem. 2003;49:1292-1296.
12. Lund G, Andersson L, Lauria M, et al. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem. 2004;279:29147-29154.
13. Chen Z, Karaplis AC, Ackerman SL, et al. Mice deficient in methyl-enetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet. 2001;10:433-443.
14. Fuke C, Shimabukuro M, Petronis A, et al. Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet. 2004;68(Pt 3):196-204.
15. Bollati V, Schwartz J, Wright R, et al. Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev. 2009;130:234-239.
16. Ting Hsiung D, Marsit CJ, Houseman EA, et al. Global DNA methyl-ation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2007;16:108-114.
17. Ingrosso D, Cimmino A, Perna AF, et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocys-teinaemia in patients with uraemia. Lancet. 2003;361:1693-1699.
18. Baccarelli A, Wright RO, Bollati V, et al. Rapid DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care Med. 2009;179:572-578.
19. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci \USA. 2007;104:13056-13061.
20. Antoniades C, Antonopoulos AS, Tousoulis D, Marinou K, Stefanadis C. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J. 2009;30:6-15.
21. Marti-Carvajal AJ, Sola I, Lathyris D, Salanti G. Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2009:CD006612.
22. Zaina S, Lindholm MW, Lund G. Nutrition and aberrant DNA methyl-ation patterns in atherosclerosis: more than just hyperhomocysteinemia? J Nutr. 2005;135:5-8.
23. Bell B, Rose C, Damon A. The normative aging study: an interdisciplinary and longitudinal study of health and aging. Aging Hum Dev. 1972;3:4-17.
24. Kawachi I, Sparrow D, Spiro A III, Vokonas P, Weiss ST. A prospective study of anger and coronary heart disease. The Normative Aging Study. Circulation. 1996;94:2090-2095.
25. Todaro JF, Shen BJ, Niaura R, Spiro A III, Ward KD. Effect of negative emotions on frequency of coronary heart disease (The Normative Aging Study). Am J Cardiol. 2003;92:901-906.
26. Kubzansky LD, Sparrow D, Vokonas P, Kawachi I. Is the glass half empty or half full? A prospective study of optimism and coronary heart disease in the normative aging study. Psychosom Med. 2001;63:910-916.
27. Bollati V, Baccarelli A, Hou L, et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 2007;67: 876-880.
28. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. New Engl J Med. 2008;359:61-73.
29. Newman PE. Can reduced folic acid and vitamin B12 levels cause deficient DNA methylation producing mutations which initiate atherosclerosis? Med Hypotheses. 1999;53:421-424.
30. Bjornsson HT, Sigurdsson MI, Fallin MD, et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA. 2008; 299:2877-2883.
31. Jasinska A, Krzyzosiak WJ. Repetitive sequences that shape the human transcriptome. FEBS Lett. 2004;567:136-141.
32. Li TH, Schmid CW. Differential stress induction of individual Alu loci: implications for transcription and retrotransposition. Gene. 2001;276: 135-141.
33. Lucchinetti E, Feng J, Silva R, et al. Inhibition of LINE-1 expression in the heart decreases ischemic damage by activation of Akt/PKB signaling. Physiol Genomics. 2006;25:314-324.
34. Zhu S, Goldschmidt-Clermont PJ, Dong C. Inactivation of monocar-boxylate transporter MCT3 by DNA methylation in atherosclerosis. Circulation. 2005;112:1353-1361.
35. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res. 1999;43:985-991.
36. Tarantini L, Bonzini M, Apostoli P, et al. Effects of particulate matter on genomic DNA methylation content and iNOS promoter methylation. Environ Health Perspect. 2009;117:217-222.
37. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361:393-395.